p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.
- DOI
- 10.1158/1078-0432.ccr-24-3848
- Published
- 2025-07-01
- Container
- Clin Cancer Res
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1158/1078-0432.ccr-24-3848,
title = {p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.},
author = {Werneck Gomes H and Lister NL and Keerthikumar S and Niranjan B and Richards MG and Ryan A and Kwan EM and Risbridger GP and Taylor RA.},
year = {2025},
journal = {Clin Cancer Res},
doi = {10.1158/1078-0432.ccr-24-3848},
url = {https://doi.org/10.1158/1078-0432.ccr-24-3848}
}RIS
TY - JOUR TI - p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer. AU - Werneck Gomes H AU - Lister NL AU - Keerthikumar S AU - Niranjan B AU - Richards MG AU - Ryan A AU - Kwan EM AU - Risbridger GP AU - Taylor RA. PY - 2025 JO - Clin Cancer Res DO - 10.1158/1078-0432.ccr-24-3848 UR - https://doi.org/10.1158/1078-0432.ccr-24-3848 ER -
APA
H, W. G., NL, L., S, K., B, N., MG, R., A, R., EM, K., GP, R., & RA., T. (2025). p-AKT Protein Expression Predicts Response to AKT Inhibitor Combined with Docetaxel Therapy in Adenocarcinoma and Neuroendocrine Prostate Cancer.. Clin Cancer Res. https://doi.org/10.1158/1078-0432.ccr-24-3848
Source records
- europe-pmc · retrieved 2026-09-26T08:57:04.863Z